Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGS | Information Technology
Market Fundamentals
Stock Intelligence & News
Aarey Drugs & Pharmaceuticals Limited
Nimit Rajesh Ghatalia has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs and Pharmaceuticals Limited has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Mumbai: Unauthorised Dargah Demolition Underway At Aarey Colony Under Heavy Police Protection | Watch Video
Mumbai authorities conducted an anti-encroachment drive to demolish an alleged illegal dargah in Aarey Colony
Read Full Analysis →Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Aarey Drugs & Pharmaceuticals Limited
Board Meeting Intimation |Meeting Date: 30-May-2026
Read Full Analysis →Aarey Drugs & Pharmaceuticals Limited
Financial Results |Meeting Date: 30-May-2026
Read Full Analysis →Aarey Drugs & Pharmaceuticals Limited
Financial Results |Meeting Date: 29-May-2026
Read Full Analysis →Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 29-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . |SUBJECT: Board Meeting Intimation
Read Full Analysis →Aarey Drugs & Pharmaceuticals Limited
The Exchange had sought clarification from Aarey Drugs & Pharmaceuticals Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed. |SUBJECT: Reply to Clarification- Financial results
Read Full Analysis →Get instant alerts when AAREYDRUGS breaks news
Join investors who track Aarey Drugs & Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for AAREYDRUGS?
AAREYDRUGS is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Aarey Drugs & Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding AAREYDRUGS to your custom watchlist.